Abstract:
The present technology provides methods and compositions for the treatment of tissue-damage related immune dysregulation by administering a composition comprising one or more of CD24; CD24 fragments, variants and derivatives, CD24Fc fusion proteins; HMBG1-binding proteins, binding proteins to HMBG1 Box B; antagonists of HMGB1, polyclonal, monoclonal, recombinant, chimeric, humanized scFv antibodies and antibody fragments to HMGB1 or fragments of HMGB1 and antibodies that bind and suppress the activity of HMGB1 Box B; Siglec 10 agonists such as anti-Siglec 10 antibodies; and combinations thereof to a patient.
Abstract:
The present application discloses a backlight module and a display device. The backlight module includes a substrate, a plurality of LED chips, and a sealant layer. The plurality of LED chips are arranged on the substrate at intervals, and the sealant layer is arranged on the substrate and covers the plurality of LED chips; the sealant layer is provided with a plurality of recesses on a side away from the LED chips, and the plurality of recesses is arranged above the plurality of LED chips in a one-to-one correspondence to the plurality of LED chips, so that light directly above the LED chips is opened to surroundings, and side light emission of the LED chips is increased, thereby increasing brightness of an area between adjacent ones of the LED chips, thus reducing a probability of dark shadows occurring.